Related Experiment Videos
Transfusion therapy for erythropoietic protoporphyria
The British Journal of Dermatology
|November 1, 1983
Summary
Red blood cell transfusions effectively reduced photosensitivity and protoporphyrin levels in patients with erythropoietic protoporphyria. This approach offers a potential therapeutic option for managing severe hepatic dysfunction.
Area of Science:
- Hepatology
- Hematology
- Biochemistry
Background:
- Erythropoietic protoporphyria (EPP) is a rare genetic disorder.
- Patients experience severe photosensitivity due to protoporphyrin accumulation.
- Previous treatments like beta-carotene were unsuccessful in some cases.
Purpose of the Study:
- To evaluate the efficacy of red blood cell transfusions in managing EPP.
- To assess the impact of transfusions on protoporphyrin levels and photosensitivity.
- To explore a potential treatment for EPP with hepatic deterioration.
Main Methods:
- Five EPP patients received 5-6 transfusions of washed, packed red blood cells.
- Protoporphyrin levels and photosensitivity were monitored post-transfusion.
Main Results:
- Transfusions led to a significant decrease in red blood cell protoporphyrin levels.
- Patient photosensitivity was considerably reduced after transfusions.
- The treatment showed promise in managing EPP complications.
Conclusions:
- Red blood cell transfusions are a viable therapeutic option for EPP.
- This method can effectively lower protoporphyrin levels and alleviate photosensitivity.
- It may be beneficial for EPP patients with worsening liver function.